Ardelyx (ARDX) Share-based Compensation (2013 - 2026)
Ardelyx posted quarterly Share-based Compensation of $14.2 million for Q1 2026, up 17.12% year-on-year from $12.1 million in Q1 2025, and up 13.76% on a QoQ basis from $12.4 million in Q4 2025.
Ardelyx (ARDX) has 14 years of Share-based Compensation data on file, last reported at $14.2 million in Q1 2026.
- For the quarter ending Q1 2026, Share-based Compensation rose 17.12% year-over-year to $14.2 million; the trailing twelve-month figure through Mar 2026 stood at $51.0 million (up 21.93% YoY), and the FY2025 full-year result was $49.0 million, up 30.98% from the prior year.
- Share-based Compensation for Q1 2026 stood at $14.2 million, up from $12.4 million in the prior quarter.
- Across five years, Share-based Compensation topped out at $14.2 million in Q1 2026 and bottomed at $1.8 million in Q3 2022.
- The 5-year median for Share-based Compensation is $7.6 million (2024), against an average of $7.3 million.
- The widest annual swing landed in 2022, when Share-based Compensation sank 44.51%; it then surged 236.64% in 2024.
- A 5-year view of Share-based Compensation shows it stood at $1.9 million in 2022, then jumped by 104.05% to $3.9 million in 2023, then surged by 150.97% to $9.9 million in 2024, then rose by 26.18% to $12.4 million in 2025, then increased by 13.76% to $14.2 million in 2026.
- The last three Share-based Compensation figures came in at $14.2 million (Q1 2026), $12.4 million (Q4 2025), and $12.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 892,057.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 305,000.00 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 166.40 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 257.40 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 70.15 Mn |
| 10 | Ardelyx | 1.48 Bn | 1.25 Bn | 89.66 Mn | 14.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.16 Mn |
| Mar 31, 2026 | 14.16 Mn |
| Dec 31, 2025 | 12.45 Mn |
| Dec 31, 2025 | 12.45 Mn |
| Sep 30, 2025 | 12.74 Mn |
| Sep 30, 2025 | 12.74 Mn |
| Jun 30, 2025 | 11.69 Mn |
| Jun 30, 2025 | 11.69 Mn |
| Mar 31, 2025 | 12.09 Mn |
| Mar 31, 2025 | 12.09 Mn |
| Dec 31, 2024 | 9.86 Mn |
| Dec 31, 2024 | 9.86 Mn |
| Sep 30, 2024 | 9.13 Mn |
| Sep 30, 2024 | 9.13 Mn |
| Jun 30, 2024 | 10.77 Mn |
| Jun 30, 2024 | 10.77 Mn |
| Mar 31, 2024 | 7.62 Mn |
| Mar 31, 2024 | 7.62 Mn |
| Dec 31, 2023 | 3.93 Mn |
| Dec 31, 2023 | 3.93 Mn |
| Sep 30, 2023 | 3.49 Mn |
| Sep 30, 2023 | 3.49 Mn |
| Jun 30, 2023 | 3.20 Mn |
| Jun 30, 2023 | 3.20 Mn |
| Mar 31, 2023 | 2.91 Mn |
| Mar 31, 2023 | 2.91 Mn |
| Dec 31, 2022 | 1.93 Mn |
| Dec 31, 2022 | 1.93 Mn |
| Sep 30, 2022 | 1.85 Mn |
| Sep 30, 2022 | 1.85 Mn |
| Jun 30, 2022 | 3.25 Mn |
| Jun 30, 2022 | 3.25 Mn |
| Mar 31, 2022 | 3.72 Mn |
| Mar 31, 2022 | 3.72 Mn |
| Dec 31, 2021 | 3.47 Mn |
| Dec 31, 2021 | 3.47 Mn |
| Sep 30, 2021 | 2.26 Mn |
| Sep 30, 2021 | 2.26 Mn |
| Jun 30, 2021 | 3.22 Mn |
| Jun 30, 2021 | 3.22 Mn |
| Mar 31, 2021 | 3.09 Mn |
| Mar 31, 2021 | 3.09 Mn |
| Dec 31, 2020 | 2.43 Mn |
| Dec 31, 2020 | 2.43 Mn |
| Sep 30, 2020 | 2.53 Mn |
| Sep 30, 2020 | 2.53 Mn |
| Jun 30, 2020 | 2.67 Mn |
| Jun 30, 2020 | 2.67 Mn |
| Mar 31, 2020 | 2.95 Mn |
| Mar 31, 2020 | 2.95 Mn |
| Dec 31, 2019 | 2.21 Mn |
| Dec 31, 2019 | 2.21 Mn |
| Sep 30, 2019 | 3.88 Mn |
| Sep 30, 2019 | 3.88 Mn |
| Jun 30, 2019 | 1.92 Mn |
| Jun 30, 2019 | 1.92 Mn |
| Mar 31, 2019 | 1.92 Mn |
| Mar 31, 2019 | 1.92 Mn |
| Dec 31, 2018 | 2.25 Mn |
| Dec 31, 2018 | 2.25 Mn |
| Sep 30, 2018 | 1.95 Mn |
| Sep 30, 2018 | 1.95 Mn |
| Jun 30, 2018 | 2.60 Mn |
| Jun 30, 2018 | 2.60 Mn |
| Mar 31, 2018 | 2.43 Mn |
| Mar 31, 2018 | 2.43 Mn |
| Dec 31, 2017 | 2.59 Mn |
| Dec 31, 2017 | 2.59 Mn |
| Sep 30, 2017 | 2.10 Mn |
| Sep 30, 2017 | 2.10 Mn |
| Jun 30, 2017 | 2.79 Mn |
| Jun 30, 2017 | 2.79 Mn |
| Mar 31, 2017 | 2.11 Mn |
| Mar 31, 2017 | 2.11 Mn |
| Dec 31, 2016 | 1.55 Mn |
| Dec 31, 2016 | 1.55 Mn |
| Sep 30, 2016 | 1.29 Mn |
| Sep 30, 2016 | 1.29 Mn |
| Jun 30, 2016 | 1.29 Mn |
| Jun 30, 2016 | 1.29 Mn |
| Mar 31, 2016 | 1.19 Mn |
| Mar 31, 2016 | 1.19 Mn |
| Dec 31, 2015 | 757,000.00 |
| Dec 31, 2015 | 757,000.00 |
| Sep 30, 2015 | 712,000.00 |
| Sep 30, 2015 | 712,000.00 |
| Jun 30, 2015 | 641,000.00 |
| Jun 30, 2015 | 641,000.00 |
| Mar 31, 2015 | 524,000.00 |
| Mar 31, 2015 | 524,000.00 |
| Dec 31, 2014 | 1.21 Mn |
| Dec 31, 2014 | 1.21 Mn |
| Sep 30, 2014 | 322,000.00 |
| Sep 30, 2014 | 322,000.00 |
| Jun 30, 2014 | 99,000.00 |
| Jun 30, 2014 | 99,000.00 |
| Mar 31, 2014 | 64,000.00 |
| Mar 31, 2014 | 64,000.00 |
| Dec 31, 2013 | 73,000.00 |
| Dec 31, 2013 | 73,000.00 |
| Sep 30, 2013 | 89,000.00 |
| Sep 30, 2013 | 89,000.00 |
| Jun 30, 2013 | 82,000.00 |
| Jun 30, 2013 | 82,000.00 |